Good questions FMB. I too am interested in hearing from the company regarding actual take-up of the products by doctors and clinics in the areas where the tests have been authorized rather than simply reference to suppliers/on-sellers. Also, in their research, what has been the feedback from doctors regarding the FebriDx? Previously, doctors i assume would inform the patient that colds and flus generally do not require anti-biotics unless they progress into a bacterial infection. Ergo, do they simply trust their own judgment as a physician or rely on the FebriDx. I see this as an important question. I have emailed the questions for the Q&A discussion on Thurs.
The re-rate journey, page-481
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.001(3.13%) |
Mkt cap ! $23.11M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.2¢ | 3.0¢ | $32.35K | 1.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 207934 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 443315 | 3 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| LDX (ASX) Chart |